Business Intelligence
Medical errors are estimated to be the third-highest cause of death in the country. Experts and patient safety advocates are trying to change that. But at least one of the tools that's been considered a fix isn't yet working as well as it should, suggests a report released Thursday.
Healthcare CEOs are increasingly focused on business-level issues, a new report by The Advisory Board has found, as consumerism continues to reshape the industry.
For primary care physicians, the difference is $225,000 a year for men versus $192,000 for women. For specialists, it's $242,000 versus $173,000. However, the salaries of women increased by a greater percentage than their male counterparts.
A majority of Americans, between 58 and 71 percent, don't see price and care as intricately linked, according to findings published in Health Affairs. However, a substantial minority, 21 to 24 percent, believe there is some correlation. Eight to 16 percent said they didn't know.
A group of researchers has proposed a method for making expensive treatments for cancer, hepatitis C and other rare diseases more affordable: healthcare loans. They effectively work like a home mortgage and spread out payments for expensive treatments over time.
The healthcare system in the United States is spending billions per year unnecessarily by continuing to use manual administrative processes for basic transactions, according to the 2015 CAQH Index released Wednesday.
A new analysis of data shows patients spend about $17 billion annually treating potentially avoidable complications of diabetes, said researchers at the Health Care Incentives Improvement Institute.
Cholesterol test results obtained through Theranos Inc. were substantially different than those from large laboratory companies, implying that doctors' medical decisions could be thrown off by Theranos-acquired results, a study finds.
Mergers and consolidations should be saving hospitals money from having benefits of scale, but a new report by PwC finds this isn't the case.
Authors liken drug loans to mortgages, noting that both can enable consumers to buy big-ticket items requiring a hefty up-front payment that they could not otherwise afford.